Daniel Zank
Daniel Zank, MD, is a pulmonologist at National Jewish Health. Dr. Zank is in the Division of Pulmonary, Critical Care and Sleep Medicine.
Assistant Professor
Division of Pulmonary, Critical Care & Sleep Medicine
Department of Medicine

Education

Education
Loyola University of Chicago Stritch School of Medicine, Maywood, IL, MD
University of Wisconsin, Madison, WI, MS, Population Health Sciences
University of Wisconsin, Madison, WI, BS, Biology
Internships
University of California - San Diego, La Jolla, CA, Internal Medicine
Residency
University of Michigan, Ann Arbor, MI, Internal Medicine
Fellowship
University of Pittsburgh, Pittsburgh, PA, Division of Pulmonary, Allergy & Critical Care Medicine

Awards & Recognition

2011: University of California-San Diego, Intern of the Year
2017-2018: T32 Ruth L. Kirschstein, National Research Service Award

Board Certification

2013: American Board of Internal Medicine, Internal Medicine
2017: American Board of Internal Medicine, Pulmonary Medicine
2018: American Board of Internal Medicine, Critical Care Medicine

Professional Memberships

2011-Present: American Medical Association
2013-Present: American College of Physicians
2015-Present: American Thoracic Society

Publications

Bueno M, Zank DC, Buendia-Roldan I, et al. PINK1 attenuates mtDNA release in alveolar epithelial cells and TLR9 mediated profibrotic responses. JCI Insight, 2019, Accepted Submission.

Zank DC, Bueno M, Mora AL, Rojas M. Idiopathic pulmonary fibrosis: Aging, mitochondrial dysfunction, and cellular bioenergetics. Front Med (Lausanne) 2018;5. doi:10.3389/fmed.2018.00010.

Fendrick AM, Zank D. Value-Based Insurance Design: Aligning incentives and evidence in pulmonary medicine. Chest, 2013; 144(5): 1712-6.

Robles L, Slogoff M, Ladwig-Scott E, Zank D, Larson MK, Aranha G, Shoup M. The addition of a nurse practitioner to an inpatient surgical team results in improved use of resources. Surgery, 2011; 150(4): 711-7.

Freeberg SY, Maglione T, Amin A, Zank D, Heroux AL, et al. Efficacy of mechanical circulatory support devices for termination of drug-refractory sustained ventricular tachycardia. J Clinic Experiment Cardiol, 2011; 2: 153.

Ask a Question through Patient Portal

Sign in to your My National Jewish Health patient portal account to communicate with your care team, manage appointments, and more. Create an Account
 

Contact Information

  • Office: 877.225.5654

 

Locations

  • National Jewish Health Main Campus
    1400 Jackson St.
    Denver, CO 80206

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our independent rating system, the Press Ganey Patient Satisfaction Survey. This survey is about the patient care experience and does not address crucial characteristics like medical decision-making, prescribing the best therapy, and patient outcomes.

Responses are measured on a scale of 1 to 5, with 5 being the best score. Learn more about our patient satisfaction survey.
 
 

Comments

Comments are collected in our Press Ganey Patient Satisfaction Surveys. Patients are de-identified to protect confidentiality and patient privacy. Learn more about our patient satisfaction survey.